Cargando…

PPAR Pan Agonist MHY2013 Alleviates Renal Fibrosis in a Mouse Model by Reducing Fibroblast Activation and Epithelial Inflammation

The peroxisome proliferator-activated receptor (PPAR) nuclear receptor has been an interesting target for the treatment of chronic diseases. Although the efficacy of PPAR pan agonists in several metabolic diseases has been well studied, the effect of PPAR pan agonists on kidney fibrosis development...

Descripción completa

Detalles Bibliográficos
Autores principales: Son, Minjung, Kim, Ga Young, Yang, Yejin, Ha, Sugyeong, Kim, Jeongwon, Kim, Doyeon, Chung, Hae Young, Moon, Hyung Ryong, Chung, Ki Wung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002481/
https://www.ncbi.nlm.nih.gov/pubmed/36902313
http://dx.doi.org/10.3390/ijms24054882

Ejemplares similares